The global enteral feeding formula market is anchored by its role as an alternative nutritional solution, commonly known as tube feeding, for patients unable to consume regular diets orally due to injuries or medical conditions. This market gains momentum as the prevalence of chronic diseases rises, necessitating specialized enteral nutrition support. The demand for effective and convenient enteral feeding formulas grows alongside the increasing need for nutritional interventions. With a focus on improved patient outcomes and enhanced healthcare practices, the enteral feeding formula market thrives on its vital contribution to medical nutrition.
According to Data Bridge Market Research, the Global Enteral Feeding Formula Market was valued at USD 3,096.65 million in 2021 and is expected to reach USD 5,400.70 million by 2029, registering a CAGR of 7.20% during the forecast period of 2022-2029.
“Prevalence of chronic diseases drive the market growth”
The prevalence of chronic diseases acts as a potent driver for the global enteral feeding formula market. Conditions such as cancer, diabetes, and neurological disorders often compromise patients' ability to consume adequate nutrition orally. Enteral feeding formulas provide a vital solution, delivering essential nutrients directly and effectively. As the burden of chronic diseases continues to rise worldwide, the demand for specialized enteral nutrition support escalates. This trend underscores the crucial role of enteral feeding formulas in managing and improving the nutritional status of individuals with chronic health conditions, propelling the market growth.
What restraints the growth of the global enteral feeding formula market?
“Occurrence of feeding and medication errors”
The global enteral feeding formula market encounters a significant restraint in the occurrence of feeding and medication errors. These errors, whether due to maladministration, improper dosing, or incorrect formula selection, can lead to adverse health outcomes for patients. Such incidents highlight the critical importance of proper training and protocols in enteral feeding practices. The potential risks associated with errors may lead to increased caution among healthcare providers and could impact the overall adoption of enteral feeding formulas, posing a challenge to the market's growth.
Segmentation: Global Enteral Feeding Formula Market
The enteral feeding formula market is segmented on the basis of product, application, type of tube feeding, stage, and end user.
- On the basis of product, the enteral feeding formula market is segmented into standard formulas and disease-specific formulas.
- On the basis of application, the enteral feeding formula market is segmented into oncology, neurology, critical care, diabetes, gastroenterology, and others.
- On the basis of the type of tube feeding, the enteral feeding formula market is segmented into gastric tube feeding, nasogastric tube feeding, gastrostomy tube feeding, and duodenal or jejunal tube feeding.
- On the basis of stage, the enteral feeding formula market is segmented into adult and pediatric.
- On the basis of end user, the enteral feeding formula market is segmented into hospitals and long term care facilities.
Regional Insights: North America dominates the Global Enteral Feeding Formula Market
North America's enteral feeding formula market dominance stems from its high burden of chronic diseases such as cancer, diabetes, and neurological conditions. The region's prevalence of these ailments drives demand for specialized nutrition support through enteral feeding formulas, positioning it as a dominant market player.
Asia-Pacific (APAC) anticipates substantial growth from 2022 to 2029 due to a rising incidence of preterm births. As the region witnesses more preterm infants requiring enteral nutrition, the demand for suitable feeding formulas increases, propelling the APAC enteral feeding formula market forward?
To know more about the study visit, https://www.databridgemarketresearch.com/zh/reports/global-enteral-feeding-formulas-market
Recent Developments in Global Enteral Feeding Formula Market
- In October 2020, Nestle Health Science introduced China's inaugural ready-to-drink protein-based total nutrition Foods. This innovation, designed for Special Medical Purposes (FSMPs), addresses the nutritional needs of undernourished individuals. By offering a convenient and effective solution, Nestle's launch signifies a significant step in catering to the dietary requirements of this vulnerable demographic in China.
The Prominent Key Players Operating in the Global Enteral Feeding Formula Market Include:
- Hormel Foods Corporation (U.S.)
- Victus, Inc. (U.S.)
- Global Health Products, Inc. (U.S.)
- Medline Industries, Inc (U.S.)
- Mead Johnson & Company, LLC. (U.S.)
- Medtrition, Inc. (U.S.)
- Nutritional Medicinals, LLC (U.S.)
- Real Food Blends (U.S.)
- Nestlé Health Science (Switzerland)
- Meiji Holdings Co., Ltd. (Japan)
- Fresenius Kabi Ltd (Germany)
- B. Braun Melsungen AG
- (Germany)
- Abbott (U.S.)
Above are the key players covered in the report, to know about more and exhaustive list of global enteral feeding formula market companies contact, https://www.databridgemarketresearch.com/zh/contact
Research Methodology: Global Enteral Feeding Formula Market
Data collection and base year analysis are done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. In addition, market share analysis and key trend analysis are the major success factors in the market report. The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, global vs Regional and Vendor Share Analysis. Please request analyst call in case of further inquiry.
